{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:31:42Z","timestamp":1787725902749,"version":"build-2784847793"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Morphine tolerance limits its long-term clinical utility, and neuroinflammation is a key underlying mechanism. This study investigated whether zonisamide, an antiepileptic drug with anti-inflammatory properties, attenuates morphine-induced neuroinflammation and morphine tolerance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In vitro, BV-2 microglial cells were treated with morphine (200 \u03bcM) with or without zonisamide (10 \u03bcM). Quantitative real-time PCR, enzyme-linked immunosorbent assay (ELISA), and Western blot analysis were used to assess inflammatory mediators and signaling pathways. In vivo, male C57BL\/6 mice received repeated morphine injections (10 mg\/kg, s.c., twice daily) for 9 days to induce tolerance, with or without zonisamide (30 mg\/kg, i.p.). Behavioral tests (hot plate and tail flick) were performed to evaluate analgesic tolerance. Immunofluorescence was performed to assess microglial activation (Iba1), and Western blot analyses were conducted to evaluate TLR4 expression, p38 phosphorylation, and pro-inflammatory cytokine protein levels. Pharmacological inhibition of TLR4 with TAK-242 was used to verify the involvement of TLR4 signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In vitro, zonisamide suppressed morphine-induced upregulation of interleukin (IL)-1\u03b2, IL-6, tumor necrosis factor (TNF)-\u03b1, and Toll-like receptor 4 (TLR4) mRNA, reduced morphine-induced secretion of IL-1\u03b2, IL-6, and TNF-\u03b1 at the protein level, and inhibited morphine-induced p38 mitogen-activated protein kinase (MAPK) phosphorylation. In vivo, zonisamide did not affect acute morphine analgesia but significantly attenuated the development of chronic morphine tolerance. Spinal cord analyses revealed that zonisamide reduced microglial activation (Iba1), TLR4 expression, p38 phosphorylation, and pro-inflammatory cytokine (IL-1\u03b2, TNF-\u03b1) protein levels. Pharmacological inhibition of TLR4 with TAK-242 produced a behavioral effect similar to that of zonisamide, and combined treatment did not provide additional benefit, suggesting overlapping signaling effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings indicate that zonisamide attenuates morphine tolerance in association with reduced spinal TLR4\/p38 MAPK signaling and neuroinflammation. This study provides a mechanistic rationale for repurposing zonisamide as an adjunct therapy to improve long-term pain management and mitigate opioid-related adverse effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1893236","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:04:35Z","timestamp":1787724275000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Zonisamide attenuates morphine tolerance in association with reduced spinal TLR4\/p38 MAPK signaling"],"prefix":"10.3389","volume":"17","author":[{"given":"Li-Ba","family":"Gei","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Peking University Cancer Hospital (Inner Mongolia Campus)\/Affiliated Cancer Hospital of Inner Mongolia Medical University\/Inner Mongolia Cancer Center\/Inner Mongolia Cancer Hospital","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hua","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing), Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Peking University Cancer Hospital (Inner Mongolia Campus)\/Affiliated Cancer Hospital of Inner Mongolia Medical University\/Inner Mongolia Cancer Center\/Inner Mongolia Cancer Hospital","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Peking University Cancer Hospital (Inner Mongolia Campus)\/Affiliated Cancer Hospital of Inner Mongolia Medical University\/Inner Mongolia Cancer Center\/Inner Mongolia Cancer Hospital","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Lu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Peking University Cancer Hospital (Inner Mongolia Campus)\/Affiliated Cancer Hospital of Inner Mongolia Medical University\/Inner Mongolia Cancer Center\/Inner Mongolia Cancer Hospital","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Peking University Cancer Hospital (Inner Mongolia Campus)\/Affiliated Cancer Hospital of Inner Mongolia Medical University\/Inner Mongolia Cancer Center\/Inner Mongolia Cancer Hospital","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xia","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Peking University Cancer Hospital (Inner Mongolia Campus)\/Affiliated Cancer Hospital of Inner Mongolia Medical University\/Inner Mongolia Cancer Center\/Inner Mongolia Cancer Hospital","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Juan","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Peking University Cancer Hospital (Inner Mongolia Campus)\/Affiliated Cancer Hospital of Inner Mongolia Medical University\/Inner Mongolia Cancer Center\/Inner Mongolia Cancer Hospital","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-An","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Huizhou Municipal Central Hospital","place":["Huizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ri-Qi","family":"E","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Peking University Cancer Hospital (Inner Mongolia Campus)\/Affiliated Cancer Hospital of Inner Mongolia Medical University\/Inner Mongolia Cancer Center\/Inner Mongolia Cancer Hospital","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Tai","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s11064-010-0215-2","article-title":"Blockade of nitric oxide overproduction and oxidative stress by Nigella sativa oil attenuates morphine-induced tolerance and dependence in mice","volume":"35","author":"Abdel-Zaher","year":"2010","journal-title":"Neurochem. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11064-025-04573-x","article-title":"TLRs\/PI3K\/AKT1B signaling pathway is involved in modulation of neuroinflammation in the rat hippocampus by alpha-pinene in morphine-dependent and withdrawing rats","volume":"50","author":"Ahmadi","year":"2025","journal-title":"Neurochem. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.21885","article-title":"Neuroprotective effects of zonisamide target astrocyte","volume":"67","author":"Asanuma","year":"2010","journal-title":"Ann. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3390\/life14070795","article-title":"Zonisamide ameliorated the apoptosis and inflammation in cerebellar tissue of induced alcohol addiction animal model","volume":"14","author":"A\u015f\u0131r","year":"2024","journal-title":"Life (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1526-4637.2005.05035.x","article-title":"Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study","volume":"6","author":"Atli","year":"2005","journal-title":"Pain Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"110590","DOI":"10.1016\/j.neuropharm.2025.110590","article-title":"Bifidobacterium pseudolongum attenuates morphine tolerance via TLR4 in a male mouse model of bone cancer pain","volume":"278","author":"Cao","year":"2025","journal-title":"Neuropharmacology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12035-009-8074-z","article-title":"The role of mitogen-activated protein kinase (MAPK) in morphine tolerance and dependence","volume":"40","author":"Chen","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/bjp.2008.100","article-title":"Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction","volume":"154","author":"Christie","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"8526","DOI":"10.1096\/fj.202000154RR","article-title":"TRPC1\/4\/5 channels contribute to morphine-induced analgesic tolerance and hyperalgesia by enhancing spinal synaptic potentiation and structural plasticity","volume":"34","author":"Chu","year":"2020","journal-title":"FASEB J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bbi.2007.07.014","article-title":"A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia","volume":"22","author":"Cui","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"176173","DOI":"10.1016\/j.ejphar.2023.176173","article-title":"Amiloride alleviates morphine tolerance by suppressing ASIC3-dependent neuroinflammation in the spinal cord","volume":"963","author":"Gei","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/ejp.511","article-title":"Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling","volume":"18","author":"Han","year":"2014","journal-title":"Eur. J. Pain"},{"key":"B14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.expneurol.2018.07.005","article-title":"The anti-parkinsonian drug zonisamide reduces neuroinflammation: role of microglial Nav 1.6","volume":"308","author":"Hossain","year":"2018","journal-title":"Exp. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s40265-013-0093-4","article-title":"Zonisamide: a review of its use in the management of adults with partial seizures","volume":"73","author":"Hoy","year":"2013","journal-title":"Drugs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/ejp.617","article-title":"Selective suppression of microglial activation by paeoniflorin attenuates morphine tolerance","volume":"19","author":"Jiang","year":"2014","journal-title":"Eur. J. Pain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1038\/s41467-024-54054-y","article-title":"FLT3 signaling inhibition abrogates opioid tolerance and hyperalgesia while preserving analgesia","volume":"15","author":"Jouvenel","year":"2024","journal-title":"Nat. Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"118577","DOI":"10.1016\/j.lfs.2020.118577","article-title":"Zonisamide ameliorates neuropathic pain partly by suppressing microglial activation in the spinal cord in a mouse model","volume":"263","author":"Koshimizu","year":"2020","journal-title":"Life Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1517\/17425255.4.4.493","article-title":"Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety","volume":"4","author":"Kothare","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s10787-018-0478-9","article-title":"A mechanistic approach to explore the neuroprotective potential of zonisamide in seizures","volume":"26","author":"Kumar","year":"2018","journal-title":"Inflammopharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1111\/bph.15169","article-title":"Spinal heat shock protein 27 participates in PDGFR\u03b2-mediated morphine tolerance through PI3K\/Akt and p38 MAPK signalling pathways","volume":"177","author":"Li","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2174\/1570159X15666171128144441","article-title":"Targeting cytokines for morphine tolerance: a narrative review","volume":"17","author":"Liu","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/j.1528-1157.1997.tb01479.x","article-title":"Protective effect of zonisamide, an antiepileptic drug, against transient focal cerebral ischemia with middle cerebral artery occlusion-reperfusion in rats","volume":"38","author":"Minato","year":"1997","journal-title":"Epilepsia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1097\/j.pain.0000000000001817","article-title":"Outcomes of prescription opioid dose escalation for chronic pain: results from a prospective cohort study","volume":"161","author":"Morasco","year":"2020","journal-title":"Pain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12974-016-0754-9","article-title":"Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation","volume":"13","author":"Pan","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12974-017-0997-0","article-title":"Blocking ATP-sensitive potassium channel alleviates morphine tolerance by inhibiting HSP70-TLR4-NLRP3-mediated neuroinflammation","volume":"14","author":"Qu","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"100004","DOI":"10.1124\/pharmrev.124.001125","article-title":"Multi- and polypharmacology of carbonic anhydrase inhibitors","volume":"77","author":"Supuran","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12964-025-02181-4","article-title":"NETs activate the GAS6-AXL-NLRP3 axis in macrophages to drive morphine tolerance","volume":"23","author":"Tian","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"B29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.1824728","article-title":"Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801","volume":"251","author":"Trujillo","year":"1991","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2147\/JIR.S266995","article-title":"Spinal TLR4\/P2X7 receptor-dependent NLRP3 inflammasome activation contributes to the development of tolerance to morphine-induced antinociception","volume":"13","author":"Wang","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"105482","DOI":"10.1016\/j.phrs.2021.105482","article-title":"Microglial TLR4-induced TAK1 phosphorylation and NLRP3 activation mediates neuroinflammation and contributes to chronic morphine-induced antinociceptive tolerance","volume":"165","author":"Wang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"929222","DOI":"10.3389\/fimmu.2022.929222","article-title":"Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0929-6646(11)60074-0","article-title":"Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance","volume":"110","author":"Wen","year":"2011","journal-title":"J. Formos. Med. Assoc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of \u03bc-opioid receptors: desensitization, phosphorylation, internalization, and tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"156737","DOI":"10.1016\/j.cyto.2024.156737","article-title":"Morphine induces inflammatory responses via both TLR4 and cGAS-STING signaling pathways","volume":"183","author":"Xie","year":"2024","journal-title":"Cytokine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12974-017-0983-6","article-title":"Lidocaine alleviates morphine tolerance via AMPK-SOCS3-dependent neuroinflammation suppression in the spinal cord","volume":"14","author":"Zhang","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1499799","DOI":"10.3389\/fphar.2024.1499799","article-title":"Microglia in morphine tolerance: cellular and molecular mechanisms and therapeutic potential","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1893236\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:04:36Z","timestamp":1787724276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1893236\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":37,"alternative-id":["10.3389\/fphar.2026.1893236"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1893236","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"article-number":"1893236"}}